sb 203580 has been researched along with tubercidin in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (tubercidin) | Trials (tubercidin) | Recent Studies (post-2010) (tubercidin) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 743 | 1 | 114 |
| Protein | Taxonomy | sb 203580 (IC50) | tubercidin (IC50) |
|---|---|---|---|
| Adenosine kinase | Homo sapiens (human) | 10 | |
| Programmed cell death protein 4 | Homo sapiens (human) | 0.88 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coll, JT; Fleming, MA; Ford, PJ; Fox, T; Galullo, V; Germann, UA; Pazhanisamy, S; Porter, MD; Su, MS; Wilson, KP; Xie, X | 1 |
1 other study(ies) available for sb 203580 and tubercidin
| Article | Year |
|---|---|
A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase.
Topics: Adenosine Triphosphate; Amino Acid Substitution; Animals; Binding Sites; Calcium-Calmodulin-Dependent Protein Kinases; Crystallization; Crystallography, X-Ray; Enzyme Inhibitors; Humans; Hydrogen Bonding; Imidazoles; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinases; Models, Molecular; Mutagenesis; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Structure-Activity Relationship; Tubercidin | 1998 |